Our US Grantees

andrew rezvanni

Andrew Rezvani, M.D.

Fred Hutchinson Cancer Research Center The Role of Rituximab in Allogeneic Hematopoietic Cell Transplantation for B-Cell Non-Hodgkin Lymphoma...more

anil prasad

Anil Prasad, Ph.D.

Beth Israel Deaconess Medical Center Characterization of Cannabidiol (CBD) as a Novel Therapy for Mantle Cell Lymphoma...more

anthony brickner

Anthony G. Brickner, Ph.D.

University of Pittsburgh Cancer Institute Identifying stop codon-generated minor histocompatibility antigens capable of eliciting potent GVL or GVHD alloresponses...more

anthony letai

Anthony G. Letai, M.D., Ph.D.

Dana-Farber Cancer Institute, Harvard University Detecting blocks in Apoptosis in Leukemia Stem Cells...more

alizadeh11

Arash Ash Alizadeh, M.D., Ph.D.

Stanford University School of MedicineProspective Validation and Genetic Basis of a Novel Molecular Risk Predictor for Diffuse large B-Cell Lymphoma...more

ari melnick

Ari M. Melnick, M.D.

Albert Einstein College of Medicine The Bcl-6 oncoprotein as a target for transcription therapy...more

banerjee11

Arnob Banerjee, M.D., Ph.D.

University of Maryland School of MedicineGenomic and Functional Identification of Critical Targets in Peripheral T Cell Lymphoma...more

arun

Arun P. Wiita, MD, PhD

University of California, San Francisco Blockade of the HSP70-BAG3 chaperone/co-chaperone interaction to overcome proteasome inhibitor-refractory multiple myeloma...more

chapuis

Aude Chapuis, MD

Fred Hutchinson Cancer Research Center WT1-targeting adoptive T cell therapy for AML patients at high risk for relapse...more

ben croker

Ben A. Croker, PhD

Boston Children's HospitalGene editing in ALL to promote immunomodulatory forms of lytic cell death...more

ebert11

Benjamin L. Ebert, M.D., Ph.D.*

Dana-Farber Cancer InstituteIdentification of genetic dependencies in leukemia stem cells...more

knoechel

Birgit Knoechel, MD, PhD

Dana-Farber Cancer Institute Enhancer rewiring in drug resistant T-ALL and its therapeutic implications...more

boglarka gyukorcza

Boglarka Gyurkocza, M.D.

Fred Hutchinson Cancer Research CenterReducing Relapse of Acute Myeloid Leukemia after Hematopoietic Cell Transplantation...more

boyigan

Boyi Gan, Ph.D.

MD Anderson Cancer CenterStudy Energy Sensing Signaling in Leukemia Stem Cells and Leukemia Development...more

chengcheng zhang

Chengcheng (Alec) Zhang, Ph.D.

University of Texas, Southwestern Ex Vivo expansion of hematopoietic stem cells for cord blood and allogeneic transplantations...more

christopher oakes

Christopher Oakes, PhD

The Ohio State University The Role of EGR in establishing a malignant epigenetic program of therapy resistance in CLL...more

chuan he

Chuan He, Ph.D.

The University of Chicago Improving the Efficiency of Alkylation Anticancer Chemotherapies...more

Craig Okada, M.D.

Oregon Health & Science University Tumor Antigen Receptor Vaccines for Active Immunotherapy of T Cell Malignancies...more

nakadabaylor

Daisuke Nakada, PhD

Baylor College of Medicine Metabolic regulation of leukemia stem cells...more

starcznowski

Daniel Starczynowski, Ph.D.

Cincinnati Children's Hospital Defining the role and therapeutic potential of TNF receptor-associated factor 6 in Myelodysplastic Syndromes...more